Doxorubicin Market Research Report Information by Application (liver cancer, lung cancer), By Distribution Channel (hospital pharmacy, retail pharmacy) - Forecast Till 2032
ID: MRFR/MED/5907-HCR | 85 Pages | Author: Rahul Gotadki| November 2024
Leading companies partner with us for data-driven Insights
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Doxorubicin Market, by Application
6.1 Introduction
6.2 Liver cancer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Gastric cancer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Breast cancer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5 Bone sarcoma
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6 Prostate cancer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.7 Stomach Cancer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.8 Ovarian cancer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.9 Leukemia
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.10 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global DoxorubicinMarket, by Distribution Channel
7.1 Introduction
7.2 Hospital pharmacy
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Retail pharmacy
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Doxorubicin Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 Latin America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Pfizer, Inc.
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Sun Pharmaceutical Industries Ltd..
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Janssen Pharmaceuticals
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Accord Healthcare.
10.4.1 Company Overview
10.4.2 Technologys/Business Segment Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Novartis AG.
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Sandoz.
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Dr. Reddy’s Laboratories Ltd.
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Teva Pharmaceuticals
10.8.1 Overview
10.8.2 Treatment Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 GLENMARK PHARMACEUTICALS LTD.
10.9.1 Overview
10.9.2 Treatment Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Others.
10.10.1 Overview
10.10.2 Treatment Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
Chapter 11. Appendix
LIST OF TABLES
Table 1 Global Doxorubicin Market Synopsis, 2020-2027
Table 2 Global Doxorubicin Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Doxorubicin Market, by Region, 2020-2027 (USD Million)
Table 4 North America: DoxorubicinMarket, by Application, 2020-2027 (USD
Million)
Table 5 North America: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD
Million)
Table 6 US: Doxorubicin Market, by Application , 2020-2027 (USD Million)
Table 7 US: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD Million)
Table 8 Canada: Doxorubicin Market, by Application, 2020-2027 (USD
Million)
Table 9 Canada: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD
Million)
Table 10 South America: Doxorubicin Market, by Application, 2020-2027 (USD
Million)
Table 11 South America: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD
Million)
Table 12 Europe: Doxorubicin Market, by Application, 2020-2027 (USD Million)
Table 13 Europe: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD Million)
Table 14 Western Europe: Doxorubicin Market, by Application, 2020-2027
(USD Million)
Table 15 Western Europe: Doxorubicin Market, by Distribution Channel, 2020-2027
(USD Million)
Table 16 Eastern Europe: Doxorubicin Market, by Application, 2020-2027
(USD Million)
Table 17 Eastern Europe: Doxorubicin Market, by Distribution Channel, 2020-2027
(USD Million)
Table 18 Asia-Pacific: Doxorubicin Market, by Application, 2020-2027 (USD
Million)
Table 19 Asia-Pacific: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD
Million)
Table 20 Middle East & Africa: Doxorubicin Market, by Application, 2020-2027
(USD Million)
Table 21 Middle East & Africa: Doxorubicin Market, by Distribution Channel, 2020-2027
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Doxorubicin Market
Figure 3 Segmentation Market Dynamics for Global Doxorubicin Market
Figure 4 Global Doxorubicin Market Share, by Application, 2020
Figure 5 Global Doxorubicin Market Share, by Distribution Channel, 2020
Figure 6 Global Doxorubicin Market Share, by Region, 2020
Figure 7 North America: Doxorubicin Market Share, by Country, 2020
Figure 8 Europe: Doxorubicin Market Share, by Country, 2020
Figure 9 Asia-Pacific: Doxorubicin Market Share, by Country, 2020
Figure 10 Middle East & Africa: Doxorubicin Market Share, by Country, 2020
Figure 11 Global Doxorubicin Market: Company Share Analysis, 2020 (%)
Figure 12 Pfizer, Inc: Key Financials
Figure 13 Pfizer, Inc: Segmental Revenue
Figure 14 Pfizer, Inc: Geographical Revenue
Figure 15 Sun Pharmaceutical Industries Ltd.: Key Financials
Figure 16 Sun Pharmaceutical Industries Ltd.: Segmental Revenue
Figure 17 Sun Pharmaceutical Industries Ltd.: Geographical Revenue
Figure 18 Janssen Pharmaceuticals: Key Financials
Figure 19 Janssen Pharmaceuticals: Segmental Revenue
Figure 20 Janssen Pharmaceuticals: Geographical Revenue
Figure 21 Accord Healthcare.: Key Financials
Figure 22 Accord Healthcare.: Segmental Revenue
Figure 23 Accord Healthcare.: Geographical Revenue
Figure 24 Novartis AG
Figure 25 Sandoz
Figure 26 Dr. Reddy’s Laboratories Ltd.
Figure 27 Teva Pharmaceuticals
Figure 28 GLENMARK PHARMACEUTICALS LTD
